References
Glucksberg H, Rivkin SE, Rasmussen S, et al.: Combination chemotherapy (CMFVP) vs L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes. Cancer 50: 423–434, 1982.
Bonadonna G et al.: Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 294: 405–410, 1976.
Bonadonna G et al.: Are surgical adjuvant trials altering the course of breast cancer? Semin Oncol 5: 450–464, 1978.
The Clinical Cancer Letter 3(6): 1–4, 1980.
Lee JM, Abeloff MD, Lenhard RE, Baker RR: An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast. Surg Gynecol Obstet 138: 77–80, 1974.
Canellos GP, DeVita VT, Gold GL, Chabner BA, Schein PS, Young RC: Combination chemotherapy for advanced breast cancer: response and effect on survival. Ann Int Med 84: 389–392, 1976.
Manni A, Trujillo JE, Pearson OH: Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival. Cancer Treat Rep 64: 111–116, 1980.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stevens, A.R., Thornbery, J.M. An unusual fatal marrow suppression from very brief adjuvant chemotherapy for Stage II breast cancer. Breast Cancer Res Tr 2, 412–414 (1982). https://doi.org/10.1007/BF01805887
Issue Date:
DOI: https://doi.org/10.1007/BF01805887